Abstract:Studies in the area of human brain development are critical as research on neurological and psychiatric disorders has advanced, revealing the origins of pathophysiology to be in the earliest developmental stages. Only with a more precise understanding of the genes and environments that influence the brain in these early stages can we address questions about the pathology, diagnosis, prevention and treatment of neuropsychiatric disorders of developmental origin, like autism, schizophrenia, and Tourette syndrome. A new approach for studying early developmental events is the use of induced pluripotent stem cells (iPSCs). These are cells with wide potential, similar to that of embryonic stem cells, derived from mature somatic cells. We review the protocols used to create iPSCs, including the most efficient and reliable reprogramming strategies available to date for generating iPSCs. In addition, we discuss how this new tool can be applied to neuropsychiatric research. The use of iPSCs can advance our understanding of how genes and gene products are dynamically involved in the formation of unique features of the human brain, and how aberrant genetic variation may interfere with its typical formation. The iPSC technology, if properly applied, can also address basic questions about neural differentiation such as how stem cells can be guided into general and specific neurodevelopmental pathways. Current work in neuropsychiatry with iPSCs derived from patients has focused on disorders with specific genetics deficits and those with less-defined origins; it has revealed previously unknown aspects of pathology and potential pharmacological interventions. These exciting advances based on the use of iPSCs hold promise for improving early diagnosis and, possibly, treatment of psychiatric disorders. This article is part of a Special Issue entitled 'Trends in neuropharmacology: in memory of Erminio Costa'.

Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies

Inducing Pluripotency for Disease Modeling, Drug Development and Craniofacial Applications.

Induced Pluripotent Stem Cells As a Disease Modeling and Drug Screening Platform

Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling

Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: from 2D Monolayer to 3D Organoid and Blood Brain Barrier Models.

Development of brain organoid technology derived from iPSC for the neurodegenerative disease modelling: a glance through

Application Prospect of Induced Pluripotent Stem Cells in Organoids and Cell Therapy

Induced Neural Stem/precursor Cells for Fundamental Studies and Potential Application in Neurodegenerative Diseases

iPSC for modeling neurodegenerative disorders

Pluripotent stem cells for neurodegenerative disease modeling: an expert view on their value to drug discovery

iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology

Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases

[iPS cell technologies toward overcoming neurological diseases]

An insight into the iPSCs-derived two-dimensional culture and three-dimensional organoid models for neurodegenerative disorders

Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders

Utility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological Disorders

iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders

Induced pluripotent stem cells for neural drug discovery

Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications

Human-induced pluripotent stem cells: potential for neurodegenerative diseases

Human Induced Pluripotent Stem Cells : Clinical Significance and Applications in Neurologic Diseases